Campath-1G

N/A

Report date: 2022/01/24 09:15:13

Base Information

Drug NameCampath-1G
Drug Alias NameCampath-1-IgG antibodyCampath IgG
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-CD52
TargetsCAMPATH-1 antigen
Therapy Area/IndicationsRejection of organ transplantationGraft vs Host Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Cambridge
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcUniversity Of Cambridge
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationGraft vs Host Disease

Other Information

ATC CodeN/A
Related LinksN/A